Loading...

Reno De Medici

DB:RMD
Snowflake Description

Undervalued with excellent balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
RMD
DB
€270M
Market Cap
  1. Home
  2. DE
  3. Materials
Company description

Reno De Medici S.p.A. produces and distributes carton boards primarily in Europe. The last earnings update was 19 days ago. More info.


Add to Portfolio Compare Print
  • Reno De Medici has significant price volatility in the past 3 months.
RMD Share Price and Events
7 Day Returns
-5.4%
DB:RMD
-1%
Europe Packaging
-0.2%
DE Market
1 Year Returns
-
DB:RMD
-7.8%
Europe Packaging
-9.3%
DE Market
RMD Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Reno De Medici (RMD) -5.4% -18.8% -31% - - -
Europe Packaging -1% -3.1% -12.5% -7.8% 18.5% 70.8%
DE Market -0.2% -0.8% -7.1% -9.3% 19.2% 46%
1 Year Return vs Industry and Market
  • No trading data on RMD.
  • No trading data on RMD.
Price Volatility
RMD
Industry
5yr Volatility vs Market

RMD Value

 Is Reno De Medici undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Reno De Medici to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Reno De Medici.

DB:RMD Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.1%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.5%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:RMD
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 9.5%
Packaging Unlevered Beta Simply Wall St/ S&P Global 0.58
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.576 (1 + (1- 24%) (34.77%))
0.728
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.54% + (0.8 * 9.46%)
8.11%

Discounted Cash Flow Calculation for DB:RMD using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Reno De Medici is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:RMD DCF 1st Stage: Next 5 year cash flow forecast
2019 2020 2021 2022 2023
Levered FCF (EUR, Millions) 26.70 29.50 31.60 33.84 36.24
Source Analyst x1 Analyst x1 Est @ 7.1% Est @ 7.1% Est @ 7.1%
Present Value
Discounted (@ 8.11%)
24.70 25.24 25.01 24.77 24.54
Present value of next 5 years cash flows €124.26
DB:RMD DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2023 × (1 + g) ÷ (Discount Rate – g)
= €36.24 × (1 + 0.54%) ÷ (8.11% – 0.54%)
€481.59
Present Value of Terminal Value = Terminal Value ÷ (1 + r)5
= €481.59 ÷ (1 + 8.11%)5
€326.13
DB:RMD Total Equity Value
Calculation Result
Total Equity Value = Present value of next 5 years cash flows + Terminal Value
= €124.26 + €326.13
€450.39
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €450.39 / 376.37
€1.17
DB:RMD Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:RMD represents 0.97902x of BIT:RM
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.97902x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 1.20 x 0.97902
€1.17
Value per share (EUR) From above. €1.17
Current discount Discount to share price of €0.70
= -1 x (€0.70 - €1.17) / €1.17
40.3%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Reno De Medici is available for.
Intrinsic value
40%
Share price is €0.7 vs Future cash flow value of €1.17
Current Discount Checks
For Reno De Medici to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Reno De Medici's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Reno De Medici's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Reno De Medici's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Reno De Medici's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:RMD PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in EUR €0.07
BIT:RM Share Price ** BIT (2018-11-16) in EUR €0.72
Europe Packaging Industry PE Ratio Median Figure of 30 Publicly-Listed Packaging Companies 14.41x
Germany Market PE Ratio Median Figure of 415 Publicly-Listed Companies 17.77x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Reno De Medici.

DB:RMD PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BIT:RM Share Price ÷ EPS (both in EUR)

= 0.72 ÷ 0.07

10.34x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Reno De Medici is good value based on earnings compared to the Europe Packaging industry average.
  • Reno De Medici is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Reno De Medici's expected growth come at a high price?
Raw Data
DB:RMD PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 10.34x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
6.8%per year
Europe Packaging Industry PEG Ratio Median Figure of 17 Publicly-Listed Packaging Companies 1.65x
Germany Market PEG Ratio Median Figure of 272 Publicly-Listed Companies 1.33x

*Line of best fit is calculated by linear regression .

DB:RMD PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 10.34x ÷ 6.8%

1.51x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Reno De Medici is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Reno De Medici's assets?
Raw Data
DB:RMD PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in EUR €0.50
BIT:RM Share Price * BIT (2018-11-16) in EUR €0.72
Europe Packaging Industry PB Ratio Median Figure of 35 Publicly-Listed Packaging Companies 1.72x
Germany Market PB Ratio Median Figure of 553 Publicly-Listed Companies 1.84x
DB:RMD PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BIT:RM Share Price ÷ Book Value per Share (both in EUR)

= 0.72 ÷ 0.50

1.43x

* Primary Listing of Reno De Medici.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Reno De Medici is good value based on assets compared to the Europe Packaging industry average.
X
Value checks
We assess Reno De Medici's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Packaging industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Packaging industry average (and greater than 0)? (1 check)
  5. Reno De Medici has a total score of 5/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

RMD Future Performance

 How is Reno De Medici expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
6.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Reno De Medici expected to grow at an attractive rate?
  • Reno De Medici's earnings growth is expected to exceed the low risk savings rate of 0.5%.
Growth vs Market Checks
  • Reno De Medici's earnings growth is positive but not above the Germany market average.
  • Reno De Medici's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:RMD Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:RMD Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 6.8%
DB:RMD Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 11.2%
Europe Packaging Industry Earnings Growth Rate Market Cap Weighted Average 10%
Europe Packaging Industry Revenue Growth Rate Market Cap Weighted Average 4.6%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.5%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:RMD Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:RMD Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 741 31 1
2019-12-31 730 29 1
2018-12-31 599 26 1
DB:RMD Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2018-09-30 589 27
2018-06-30 589 52 26
2018-03-31 583 25
2017-12-31 575 34 15
2017-09-30 569 12
2017-06-30 561 31 8
2017-03-31 522 3
2016-12-31 484 28 3
2016-09-30 454 4
2016-06-30 433 21 9
2016-03-31 440 10
2015-12-31 444 28 11

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Reno De Medici's earnings are expected to grow by 6.8% yearly, however this is not considered high growth (20% yearly).
  • Reno De Medici's revenue is expected to grow by 11.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:RMD Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Reno De Medici Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RMD Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.08 0.08 0.08 1.00
2019-12-31 0.08 0.08 0.08 1.00
2018-12-31 0.07 0.07 0.07 1.00
DB:RMD Past Financials Data
Date (Data in EUR Millions) EPS *
2018-09-30
2018-06-30 0.07
2018-03-31
2017-12-31 0.04
2017-09-30
2017-06-30 0.02
2017-03-31
2016-12-31 0.01
2016-09-30
2016-06-30 0.02
2016-03-31
2015-12-31 0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Reno De Medici will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Reno De Medici's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Reno De Medici has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

RMD Past Performance

  How has Reno De Medici performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Reno De Medici's growth in the last year to its industry (Packaging).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Reno De Medici has delivered over 20% year on year earnings growth in the past 5 years.
  • Reno De Medici's 1-year earnings growth exceeds its 5-year average (131.5% vs 24.8%)
  • Reno De Medici's earnings growth has exceeded the Europe Packaging industry average in the past year (131.5% vs 12%).
Earnings and Revenue History
Reno De Medici's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Reno De Medici Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:RMD Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 588.64 27.19 92.61
2018-06-30 589.19 26.11 92.26
2018-03-31 582.84 24.90 91.14
2017-12-31 574.56 14.57 90.89
2017-09-30 569.32 11.74 90.46
2017-06-30 560.68 8.19 90.50
2017-03-31 521.60 2.95 84.89
2016-12-31 483.55 3.32 78.92
2016-09-30 453.86 3.73 71.15
2016-06-30 433.13 8.52 65.67
2016-03-31 440.36 9.81 65.62
2015-12-31 443.66 10.90 65.70
2015-09-30 444.54 10.00 67.16
2015-06-30 439.03 8.33 67.29
2015-03-31 437.15 8.61 67.86
2014-12-31 439.14 10.23 68.33
2014-09-30 419.85 15.52 66.44
2014-06-30 426.09 13.72 67.53
2014-03-31 435.47 10.80 68.94
2013-12-31 443.05 4.91 70.50
2013-09-30 476.16 -4.72 76.19
2013-06-30 478.39 -7.98 76.91
2013-03-31 481.25 -10.46 77.32
2012-12-31 477.35 -12.33 77.21
2012-09-30 472.66 -7.40 75.05
2012-06-30 478.65 -8.93 74.97
2012-03-31 500.04 -6.22 75.57
2011-12-31 519.82 -1.98 77.37

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Reno De Medici has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Reno De Medici used its assets less efficiently than the Europe Packaging industry average last year based on Return on Assets.
  • Reno De Medici has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Reno De Medici's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Packaging industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Reno De Medici has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

RMD Health

 How is Reno De Medici's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Reno De Medici's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Reno De Medici is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Reno De Medici's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Reno De Medici's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Reno De Medici Company Filings, last reported 1 month ago.

DB:RMD Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 192.06 93.95 70.76
2018-06-30 188.32 60.41 29.50
2018-03-31 180.87 68.70 26.43
2017-12-31 168.47 64.06 19.13
2017-09-30 166.33 67.59 24.83
2017-06-30 163.82 67.16 14.17
2017-03-31 157.65 72.96 29.68
2016-12-31 155.22 74.22 29.33
2016-09-30 156.10 64.75 9.22
2016-06-30 157.26 64.29 2.40
2016-03-31 154.74 66.87 29.28
2015-12-31 152.42 70.27 23.15
2015-09-30 151.53 53.46 4.13
2015-06-30 148.46 58.63 2.37
2015-03-31 145.41 55.01 1.60
2014-12-31 141.56 65.67 2.38
2014-09-30 150.42 70.00 3.08
2014-06-30 148.97 77.21 4.08
2014-03-31 145.61 77.32 2.70
2013-12-31 139.94 76.39 2.72
2013-09-30 137.25 90.29 3.69
2013-06-30 136.96 90.90 2.95
2013-03-31 136.60 95.05 2.68
2012-12-31 136.72 89.84 3.14
2012-09-30 145.89 98.71 2.27
2012-06-30 148.94 96.41 11.43
2012-03-31 151.20 100.48 1.23
2011-12-31 153.29 90.32 2.56
  • Reno De Medici's level of debt (48.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (65.7% vs 48.9% today).
  • Debt is well covered by operating cash flow (54.9%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 64.6x coverage).
X
Financial health checks
We assess Reno De Medici's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Reno De Medici has a total score of 5/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

RMD Dividends

 What is Reno De Medici's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.43%
Current annual income from Reno De Medici dividends. Estimated to be 1.4% next year.
If you bought €2,000 of Reno De Medici shares you are expected to receive €9 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Reno De Medici's pays a lower dividend yield than the bottom 25% of dividend payers in Germany (1.55%).
  • Reno De Medici's dividend is below the markets top 25% of dividend payers in Germany (3.86%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:RMD Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
Europe Packaging Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 3.1%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3.1%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.6%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:RMD Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2020-12-31 0.01 1.00
2019-12-31 0.01 1.00
2018-12-31 0.01 1.00
DB:RMD Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2018-04-06 0.003 0.346
2018-03-16 0.003 0.388
2017-04-06 0.003 0.542
2016-04-06 0.005 1.667
2016-02-12 0.005 1.602

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Reno De Medici is not paying a notable dividend for Germany, therefore no need to check if the payments are stable.
  • Reno De Medici is not paying a notable dividend for Germany, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Reno De Medici's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Reno De Medici's dividends as it is not paying a notable one for Germany.
Future Payout to shareholders
  • Dividends after 3 years are expected to be thoroughly covered by earnings (8x coverage).
X
Income/ dividend checks
We assess Reno De Medici's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Reno De Medici afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Reno De Medici has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

RMD Management

 What is the CEO of Reno De Medici's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Michele Bianchi
AGE 47
TENURE AS CEO 2 years
CEO Bio

Mr. Michele Bianchi has been President and Chief Executive Officer of Reno De Medici S.p.A. since November 2, 2016. Mr. Bianchi has been General Manager of Reno De Medici S.p.A. since November 2016 and Executive Director since November 3, 2016. He holds an Master Degree in Chemical Engineering from Pisa University,

CEO Compensation
  • Insufficient data for Michele to compare compensation growth.
  • Insufficient data for Michele to establish whether their remuneration is reasonable compared to companies of similar size in Germany.
Management Team Tenure

Average tenure of the Reno De Medici management team in years:

8.9
Average Tenure
  • The average tenure for the Reno De Medici management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Michele Bianchi

TITLE
CEO, GM & Executive Director
AGE
47
TENURE
2 yrs

Stefano Moccagatta

TITLE
CFO and Finance & Control Director
TENURE
10 yrs

Chiara Borgini

TITLE
Investor Relations Officer
TENURE
0.6 yrs

Veronica Arciuolo

TITLE
Head of Legal & Corporate Affairs and Secretary to the board

Stèphane Thiollier

TITLE
Marketing and Sales Manager
AGE
46

Marita Lovera

TITLE
Head of Human Resources
TENURE
8.9 yrs

Guido Vigorelli

TITLE
Head of Procurement & Logistics
TENURE
9.2 yrs

Manfred Stemmer

TITLE
Executive Officer

Silvano Giorgis

TITLE
Mill Director

Alessandro Magnoni

TITLE
Mill Director
Board of Directors Tenure

Average tenure and age of the Reno De Medici board of directors in years:

1.8
Average Tenure
53
Average Age
  • The average tenure for the Reno De Medici board of directors is less than 3 years, this suggests a new board.
Board of Directors

Éric Laflamme

TITLE
Chairman
AGE
54
TENURE
1.6 yrs

Michele Bianchi

TITLE
CEO, GM & Executive Director
AGE
47
TENURE
2 yrs

Giovanni Burani

TITLE
Honorary Chairman of the Board
COMPENSATION
€454K

Mario Cane

TITLE
Chairman of Reno De Medici Iberica S L
COMPENSATION
€79K

Giancarlo Corvace

TITLE
Chairman of Board of Statutory Auditors
AGE
65

Giulio Antonello

TITLE
Independent Director
COMPENSATION
€13K
AGE
50
TENURE
7.6 yrs

Laura Guazzoni

TITLE
Non-Executive-Independent Director
COMPENSATION
€90K
AGE
53

Allan Hogg

TITLE
Non-Executive Director
TENURE
2.4 yrs

Sara Rizzon

TITLE
Director
TENURE
1.6 yrs

Gloria Marino

TITLE
Independent Director
TENURE
1.6 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Reno De Medici's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Reno De Medici has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

RMD News

External News
Loading...
Simply Wall St News

RMD Company Info

Map
Description

Reno De Medici S.p.A. produces and distributes carton boards primarily in Europe. The company operates through three segments: White Lined Chipboard, Folding Box Board, and Laminated Board. It primarily offers carton boards for specialties, luxury packaging, and binding applications through a network of agents. The company was founded in 1967 and is based in Milan, Italy. Reno De Medici S.p.A. is a subsidiary of Cascades Inc.

Details
Name: Reno De Medici S.p.A.
RMD
Exchange: DB
Founded: 1967
€270,231,387
376,366,835
Website: http://www.rdmgroup.com
Address: Reno De Medici S.p.A.
Viale Isonzo 25,
Milan,
Milan, 20135,
Italy
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BIT RM Ordinary Shares Borsa Italiana IT EUR 16. Dec 1997
DB RMD Ordinary Shares Deutsche Boerse AG DE EUR 16. Dec 1997
LSE 0K69 Ordinary Shares London Stock Exchange GB EUR 16. Dec 1997
BME RDM Ordinary Shares Bolsas y Mercados Espanoles ES EUR 16. Dec 1997
BATS-CHIXE RMM Ordinary Shares BATS 'Chi-X Europe' GB EUR 16. Dec 1997
BATS-CHIXE RDME Ordinary Shares BATS 'Chi-X Europe' GB EUR 16. Dec 1997
Number of employees
Current staff
Staff numbers
1,524
Reno De Medici employees.
Industry
Paper Packaging
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2018/11/19 09:17
End of day share price update: 2018/11/16 00:00
Last estimates confirmation: 2018/11/13
Last earnings filing: 2018/10/31
Last earnings reported: 2018/09/30
Last annual earnings reported: 2017/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.